Who is eligible for clinical trial NCT04199026?

Participants must meet the protocol's inclusion criteria for Metastatic Sarcoma. The stated age range is 10 Years. Confirm all requirements with the study coordinator.

Does clinical trial NCT04199026 provide travel or cost reimbursement?

Check with the site coordinator at the participating facility for travel and lodging stipend availability, and for which routine-care costs are covered.

🏛️ Verified NIH Record • Updated 2026-08-07

Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma (NCT04199026)

Pilot Trial of an Implantable Microdevice for In Vivo Drug Sensitivity Testing in Patients With Sarcomas

🟢 Recruiting Observational / Diagnostic 💊 Investigational Drug / Biologic Sponsor: M.D. Anderson Cancer Center

🩺 Plain-English Summary (8th-Grade Level)

This early phase I trial studies the side effects of implanting and removing a microdevice in patients with sarcomas that have spread to other places in the body (metastatic) or have come back (recurrent). Microdevices are rice-sized devices that are implanted into tumor tissue and are loaded with 10 different drugs that are delivered at very small doses, or "microdoses," which may only affect a very small, local area inside the tumor. The purpose of this study is to determine which drugs delivered in the microdevice affect tumor tissue in patients with sarcomas.

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (8 items) and avoid the listed exclusions (0 items).

Location: M D Anderson Cancer Center — Houston, Texas

Age range: 10 Years

🧪 Interventions in This Study

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

Patients with a biopsy-confirmed recurrent or metastatic sarcoma for which surgery is indicated as a standard of care.
10 years of age or older
Documented, signed, dated informed consent to participate in the microdevice study
Eastern Cooperative Oncology Group (ECOG) performance status of =\< 2 Exclusion:
Subjects who do not wish to undergo surgical resection, or those who are high-risk or not candidates for surgical resection
Age \< 10 years old
Women of childbearing potential without a negative pregnancy test; or women who are lactating
Allergies or prior adverse drug reactions to any of the drugs loaded within the microdevice.

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (1 Sites)

M D Anderson Cancer Center — Houston, Texas

📞 Contact the Study Coordinator

Phone: (713) 792-3626

Email: jaludwig@mdanderson.org

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Metastatic Sarcoma

64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer — Duarte, California
68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma — Los Angeles, California
Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma — Washington D.C., District of Columbia

Explore by condition: All Metastatic Sarcoma clinical trials

💡 How to Participate

Check the checklist above to see if you may qualify.
Contact the study coordinator using the phone/email above.
Ask about the visit schedule, what is covered at no cost, and any travel support.
Confirm with your own doctor before making a decision.

🏛️ View Official NIH Record ↗